Editas Medicine, Inc.EDITNASDAQ

Revenue (LTM)

$41M

+25.4% YoY

Net Income (LTM)

$-160M

+32.5% YoY

Free Cash Flow

$-166M

Revenue CAGR (5Y)

+12.2%

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	26	20↓22.8%	78↑296.3%	32↓58.6%	41↑25.4%
Gross Profit	20	13↓34.7%	72↑438.8%	32↓55.2%	35↑9.1%
Operating Income	-193	-226↓17.0%	-169↑25.1%	-251↓48.5%	-99↑60.4%
Net Income	-193	-220↓14.5%	-153↑30.5%	-237↓54.7%	-160↑32.5%
EBITDA	-188	-220↓16.8%	-163↑25.7%	-233↓42.9%	-94↑59.7%
EPS Diluted	-2.85	-3.21↓12.6%	-2.02↑37.1%	-2.88↓42.6%	-1.80↑37.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	204	142↓30.5%	124↓12.6%	132↑6.4%	147↑11.5%
Total Current Assets	507	357↓29.7%	341↓4.5%	289↓15.1%	164↓43.4%
Total Assets	677	514↓24.1%	499↓2.9%	342↓31.6%	187↓45.4%
Total Current Liabilities	47	60↑28.2%	63↑5.2%	77↑22.2%	46↓40.1%
Total Liabilities	124	154↑24.1%	150↓2.3%	207↑38.2%	159↓23.2%
Total Equity	554	361↓34.9%	349↓3.2%	134↓61.5%	27↓79.7%
Total Debt	26	44↑66.6%	49↑10.5%	35↓27.8%	77↑119.0%
Net Debt	-177	-98↑44.9%	-75↑23.0%	-97↓28.5%	-70↑27.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-164	-177↓8.3%	-132↑25.5%	-210↓59.1%	-165↑21.4%
Capital Expenditure	-8	-4↑48.4%	-5↓14.6%	-9↓87.0%	-1↑93.1%
Free Cash Flow	-172	-181↓5.6%	-137↑24.6%	-219↓60.1%	-166↑24.3%
Stock-Based Comp	43	29↓32.5%	20↓32.4%	21↑8.2%	10↓53.3%
Net Change in Cash	64	-62↓197.1%	-18↑71.2%	8↑144.1%	14↑76.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance